Top

Netherlands Heart Journal

Published in:

Open Access 01-02-2015 | Original Article

First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation

Authors: P. Gal, J. J. J. Smit, A. Adiyaman, A. R. Ramdat Misier, P. P. H. M. Delnoy, A. Elvan

Published in: Netherlands Heart Journal | Issue 2/2015

Abstract

Introduction

The endoscopic laser balloon ablation system (EAS) is a relatively novel technique to perform pulmonary vein isolation (PVI) in the treatment of atrial fibrillation (AF). The present study aimed to report the results of the first 50 patients treated in the Netherlands with the EAS in terms of procedural characteristics and AF-free survival.

Methods

Fifty patients successfully underwent EAS PVI. Median follow-up was 17 months. Mean age was 56 years, 82 % had paroxysmal AF.

Results

99 % of the pulmonary veins were successfully isolated with the EAS. Mean procedure time was 171 min and mean fluoroscopy time was 36 min. One procedure was complicated by a temporary phrenic nerve palsy (2 %). During follow-up, 58 % of patients remained free of AF without the use of antiarrhythmic drugs.

Conclusion

PVI with EAS is associated with a low risk of complications and a medium-term AF-free survival comparable with other PVI techniques.

Available only for authorised users

Calkins H, Kuck KH, Cappato R, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528–606.PubMedCrossRef

Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New Engl J Med. 1998;339:659–66.PubMedCrossRef

Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2:349–61.PubMedCrossRef

Van Belle Y, Janse P, Rivero-Ayerza MJ, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J. 2007;28:2231–7.PubMedCrossRef

Yokoyama K, Nakagawa H, Shah DC, et al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1:354–62.PubMedCrossRef

Reddy VY, Neuzil P, d’Avila A, et al. Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation? Heart Rhythm. 2008;5:353–60.PubMedCrossRef

Reddy VY, Neuzil P, Themistoclakis S, et al. Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome. Circulation. 2009;120:12–20.PubMedCrossRef

Dukkipati SR, Neuzil P, Skoda J, et al. Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2010;3:266–73.PubMedCrossRef

Dukkipati SR, Kuck KH, Neuzil P, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6:467–72.PubMedCrossRef

10.

Dukkipati SR, Neuzil P, Kautzner J, et al. The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies. Heart Rhythm. 2012;9:919–25.PubMedCrossRef

11.

Schmidt B, Metzner A, Chun KR, et al. Feasibility of circumferential pulmonary vein isolation using a novel endoscopic ablation system. Circ Arrhythm Electrophysiol. 2010;3:481–8.PubMedCrossRef

12.

Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation. http://clinicaltrials.gov/show/NCT01863472. Accessed August 13th, 2014.

13.

Cappato R, Negroni S, Pecora D, et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation. 2003;108:1599–604.PubMedCrossRef

14.

Lemola K, Hall B, Cheung P, et al. Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation. Heart Rhythm. 2004;1:197–202.PubMedCrossRef

15.

Bordignon S, Chun KR, Gunawardene M, et al. Energy titration strategies with the endoscopic ablation system: lessons from the high-dose vs. low-dose laser ablation study. Europace. 2013;15:685–9.PubMedCrossRef

Title: First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation
Authors: P. Gal
J. J. J. Smit
A. Adiyaman
A. R. Ramdat Misier
P. P. H. M. Delnoy
A. Elvan
Publication date: 01-02-2015
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 2/2015
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-014-0624-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2015

Additive value of dobutamine stress echocardiography in patients with an anomalous origin of a coronary artery

Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry)

Long-term bleeding events after mechanical aortic valve replacement in patients under the age of 60

Rationale and design of the Measuring Athlete’s Risk of Cardiovascular events (MARC) study

Sudden shortening of the paced AV delay: is this normal pacemaker function?

New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality